...
首页> 外文期刊>Journal of nuclear medicine technology >Dual-phase 99mTc-sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism.
【24h】

Dual-phase 99mTc-sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism.

机译:99mTc-sestamibi双相成像:它可用于甲状旁腺增生,并使用即时/延迟影像比率来改善甲状旁腺功能亢进症的诊断。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Dual-phase (99m)Tc-sestamibi (methoxyisobutylisonitrile [MIBI]) imaging is the technique of choice for hyperparathyroidism (HPT), especially for localizing parathyroid adenomas. Prior studies have shown its utility for detecting hyperplasia is equivocal, but we believe this is not true. We attempted to quantitate the region-of-interest counts per pixel between immediate images and delayed images (I/D ratio) and use this ratio to distinguish normal parathyroid versus hyperplasia versus adenoma. METHOD: Anterior pinhole and upper thorax images with a low-energy, high-resolution collimator at 20 min and 2 h after (99m)Tc-MIBI injection were obtained on 54 subjects. The results were analyzed retrospectively as hyperplasia, adenoma, or normal parathyroid by the persistence of activity in 2 or more foci, a solitary focus, or no activity on the delayed images. These interpretations were compared with pathology when available. I/D ratios were computed for all scans, and mean ratios were calculated for each type of pathology (normal parathyroid, hyperplasia, and adenoma). The resulting ratios were analyzed with a t test to determine significant differences between the ratios. RESULTS: Sensitivity and specificity were 96% and 88%, respectively, for parathyroid hyperplasia. Mean I/D ratios were 2.26 +/- 0.68, 2.80 +/- 0.95, and 3.10 +/- 0.77 for subjects with hyperplasia, adenoma, and normal parathyroid, respectively (hyperplasia vs. normal, P = 0.020; adenoma vs. normal, P = 0.381; hyperplasia vs. adenoma, P = 0.033). CONCLUSION: Dual-phase (99m)Tc-MIBI imaging is more sensitive and specific for parathyroid hyperplasia than reported previously, supporting its use to localize hyperplastic glands preoperatively and to help guide resection. A thyroid ratio between immediate and delayed images will aid in distinguishing hyperplasia from normal parathyroid in uncertain cases.
机译:目的:双相(99m)Tc-sestamibi(甲氧基异丁烯腈[MIBI])成像是甲状旁腺功能亢进症(HPT)特别是局部甲状旁腺腺瘤的首选技术。先前的研究表明,它在检测增生中的作用是模棱两可的,但我们认为事实并非如此。我们试图量化即时图像和延迟图像之间的每个像素的关注区域计数(I / D比),并使用该比率来区分正常的甲状旁腺,增生,腺瘤。方法:在54名受试者(99m)Tc-MIBI注射后20分钟和2小时内,用低能量,高分辨率准直仪拍摄了前针孔和上胸腔图像。回顾性分析结果为增生,腺瘤或正常甲状旁腺,原因是活动持续存在于两个或更多病灶,孤立的病灶或延迟影像上无活动。将这些解释与病理进行了比较。计算所有扫描的I / D比,并计算每种病理类型(正常的甲状旁腺,增生和腺瘤)的平均比。用t检验分析所得比率,以确定比率之间的显着差异。结果:对甲状旁腺增生的敏感性和特异性分别为96%和88%。增生,腺瘤和正常甲状旁腺的受试者的平均I / D比分别为2.26 +/- 0.68、2.80 +/- 0.95和3.10 +/- 0.77(增生与正常相比,P = 0.020;腺瘤与正常相比,P = 0.381;增生vs.腺瘤,P = 0.033)。结论:双相(99m)Tc-MIBI成像对甲状旁腺增生的敏感性和特异性比以前报道的更高,支持其在术前定位增生腺并帮助指导切除。在不确定情况下,即时图像和延迟图像之间的甲状腺比率将有助于区分增生与正常甲状旁腺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号